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Abstract  
 
Objective: The study aimed at assessing the prevalence and management of infectious 
diseases, with main focus on malaria, HIV and TB, in a rural hospital in Western Tanzania. 
Design: Spot prevalence study. 
Methods: Information gathered from staff and patient notes on ward rounds and subsequent 
interviews of patients.  
Results: Of the 102 hospitalised patients included in the study 37/102 (36%) were diagnosed 
malaria, 15/102 (15%) with HIV/AIDS and 14/102 (14%) had TB. Out of the TB positive 
individuals, 50% had a coexisting HIV infection. HIV was more frequent among the female 
patients (16%) than the male patients (13%) and the peak age group for HIV-infection was 
50-59 years old. Malaria was most frequent among children aged 0-5 years. 52% of 
hospitalised patients were treated for malaria without having the diagnosis verified by blood 
smear. The National first line antimalarial treatment was not used. 94% of hospitalised 
patients received medication. 60% of the patients were prescribed antibiotics, 35% received 
antimalarial medication, 8% followed the national guidelines for TB-treatment with Direct 
observational treatment (DOT).  
 
Conclusion: The most frequent diagnoses of this hospital, malaria, HIV and TB must 
represent a considerable burden. The difficulties in managing these infections at a hospital 
with limited access to modern laboratory equipment and well-trained staff are revealed in this 
study. More resources are needed to ensure implementation of National Guidelines and to 
optimise the health provision at BDDH. 
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 Introduction  
 
The United Republic of Tanzania (Tanzania) and the region of Kagera where this study was 
conducted are facing major health-challenges, first and foremost associated with infectious 
diseases, such as malaria, human immune deficiency virus infection (HIV-infection) and 
tuberculosis (TB). A report from Kagera has shown that less than 5% of the population live 
under appropriate sanitation conditions, and only 10% have access to safe water (1). These 
and other socio-economic aspects may be associated with the vulnerability to infectious 
diseases and difficulties in managing them. 
 
The HIV epidemic is one of the major challenges for the Tanzanian health-service, even 
though the 9% prevalence of HIV in Tanzania is among the lowest rates in Eastern Africa. 
The first case of HIV in Tanzania was reported in 1983 and was discovered in Kagera, where 
neighbouring conflict areas and immigrants have since aggravated the burden of HIV-
infection (1). Also loss of staff from HIV has increased the burden of HIV. The lack of well-
trained health-care workers in general may make it hard to manage infectious epidemics, in 
total there are only 49 doctors in the region of Kagera, with a population of 1 783 600 
(population pr doctor: 36 400) (2). 
 
 
Figure 1 and 2: Biharamulo where the study was conducted is a town in the region of Kagera, 
Northwest in Tanzania, East Africa (3). 
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The life expectancy in Tanzania rose from the 1950ies up until the end of the 1980ies, when 
the emerging HIV-epidemic led to a decrease in the mean life-span (4). Life expectancy at 
birth in Tanzania in the period 2000-2005 was 46 years for male and female. Infant and child 
mortality rate has also risen during the 1990’s. In 2004 the under five mortality rate was 165 
per 1000 live births (5).  
 
At the onset of the HIV epidemic there was a simultaneous increase of TB infection. The 
notification rate of TB in Tanzania has increased threefold from the 1980ies (6) and in 2002 
the TB prevalence was estimated to be 472/100 000. Although some increases may be due to 
staff compliance the association between HIV and TB has long since been established, and 
out of the TB infected individuals in Africa, 40% have been found to be HIV positive (6).  
 
All of the 35 million citizens in Tanzania live at risk of malaria, at least for parts of the year 
(7). The Tanzanians constitute the third largest population at risk of malaria on earth. At least 
26% of the country is prone to malaria (7). It has been estimated that one Tanzanian, nearly 
always a child, dies of malaria every five minutes (8). The number of malaria cases in 
Tanzania is 14 to 19 million per year and the estimated number of deaths is 100 000 to 
125 000, of which 80 000 are children under 5 years of age (7). In 2003 there were 
10 712 526 reported cases of Malaria in Tanzania (9). 
 
National guidelines on malaria, HIV and TB exist, and are in various degrees implemented in 
the district hospitals. There are, however, still major problems with antiretroviral therapy 
(ART) provision, among other reasons due to economical and logistic problems (10). 
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This spot prevalence study aimed at assessing the frequency and management of infectious 
diseases, with the main focus on malaria, HIV and TB, at a rural hospital in Western Tanzania 
in the dry season: 
1. To find the prevalence of the different diagnoses of all admitted patients  
2. To evaluate management of malaria, HIV and TB with regard to the National 
guidelines 
3. To assess the diagnostic procedures and possibilities 
4. Compare local data with existing knowledge in the field 
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 Material and Methods  
 
STUDY HOSPITAL AND ENCATCHMENT AREA 
The North-western highlands of Tanzania where Biharamulo is located, has two rainy seasons 
from November to December and February to May (11). Temperature, humidity and rain are 
factors that will determine the Anopheles mosquito’s chance to survive and make the malaria 
transmission possible (8). 
 
The study was conducted in June-July 2005 at Biharamulo Designated District Hospital 
(BDDH), one of four district hospitals in the region of Kagera in North-Western Tanzania. 
The population of Kagera is about 1.8 million and covers an area of 40 838km2   
The district of Biharamulo holds a population of 472 269 people (12).  
 
The hospital was founded in 1969 by a Dutch nun of the Roman Catholic Church. The 
Diocese of the district, the Rulenge Catholic Diocese still owns the hospital buildings and 
organizes the staff and hospital management. The hospital is now government funded and the 
government is also meant to supply the hospital with essential HIV-medication. 
 
BDDH had four wards comprising a maternity ward, a children’s ward, a male ward and a 
female ward. Surgical patients were mixed with medical patients. In addition, approximately 
100 patients were seen a day by Clinical Officers or Doctors at the Out Patient Department 
(OPD).  
 
Within the region of Biharamulo, there were four levels of health-care. The first level 
included “Village health posts” and the second level comprised “Dispensaries”. From level 
three, the “Health Centres”, patients could be referred to the district hospital. However, most 
patients were admitted from the OPD at the hospital, where the patients lined up early in the 
morning. 
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Figure 3: Clinical work at a village health point 
 
If strictly required, patients in need of further investigation, such as Computer Tomography or 
certain treatment, e.g. chemotherapy, were referred to a tertiary institution, Bugando hospital 
in Mwanza, which is one of the four major consultant hospitals in Tanzania. Each month 
approximately three patients were referred to Mwanza. The transport capacity was limited, 
with only one local vehicle for patient transport available, and patients were often too weak to 
travel the 7-8 hours journey by car. Approximately only once a month samples for CD-4 
testing were sent from the hospital, unless the patients themselves were able to pay the 
expenses. Laboratory results (e.g. surgical biopsies, CD 4 counts) were reported back to the 
hospital via email or fax, approximately a week later.  
 
The choice of investigation and treatment were often dependent on the patient’s economy. 
The price of a standard blood smear at BDDH was 300 TZS (0.24 USD) (appendix 5). 
However, blood-smears were performed regardless economical concerns, if considered 
strictly necessary. There was a “poor people’s fund” at the hospital, to cover expenses 
associated with emergencies and unforeseen events.  
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 STUDY POPULATION 
The selection of patients and timing of the study conduction were done along with the 
Medical Doctors (MDs) during ward rounds. These took place Mondays, Wednesdays and 
Fridays. Study observations and notes were made throughout the ward rounds. The two 
doctors in charge of the ward rounds clarified information. Some information was gathered 
immediately after the ward rounds. Each ward was visited once weekly. Unless unforeseen 
events appeared, the ward rounds occurred at an established day and time. Whether the 
patients were informed about the timing of the ward rounds is unknown. Data were collected 
over a period of three weeks July 2005. The maternity-, male- and female wards were visited 
twice and the children’s ward was visited once. In order to calculate the average prevalence, 
the number of registered patients in the adult wards for 2 days was divided by 2. 
 
As shown in table 1, the number of beds in the children’s ward was 44. However, up to three 
children shared a bed, and the number of children hospitalised at the time of study conduction 
was 50. Children above the age of five years, were generally placed in the male or female 
wards, however, children up to eleven years were often seen in the children’s ward due to 
shortage of beds.  
 
The maternity ward comprised women who choose to deliver at hospital, women with 
complicated pregnancies, and babies up to the age of one month. Surgical, medical or 
psychiatric cases were mixed in the female and male wards.  
 
Hospitalised patients seen at the major ward rounds were invited into the study. Patients were 
included during the major ward rounds. The children below the age of one month at the 
maternity ward were excluded from the study. Patients reluctant to participate, patients who 
had left the room and patients who were too weak to answer were excluded from being 
questioned. However basic information (duration of stay, diagnosis and treatment) was 
gathered from the patient notes when possible.   
 
CLINICAL INFORMATION 
Patient notes were used as the most important source of information. The registered 
symptoms were present at the time of the study, with main focus on common symptoms 
associated with infectious diseases (appendix 4). Growth charts could not be observed at the 
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children’s ward, due to unavailability at the hospital. The data collected at the maternity ward 
focused on urinary symptoms and recorded notes.  
 
A pilot was conducted to test the questionnaire on a limited number of patients under 
supervision from local doctors and nurses, in order to see whether a translator was required, 
and to improve it. Together with the staff at BDDH, we concluded that the study could be 
conducted without a permanent translator, despite some language problems.  
 
Some patients classified into several diagnostic groups. These individuals were classified with 
the diagnosis for which they were treated as their primary diagnosis. The HIV group 
comprised the patients with HIV as the primary or secondary diagnosis. The AIDS diagnosis 
(Acquired Immune Deficiency Disease) was determined by using World Health 
Organisation’s (WHO) criteria (13). In the data collection form some terms were used that 
needed a more accurate definition. Vomiting and diarrhoea per 24 hours were the number of 
episodes with vomit and diarrhoea today and yesterday. 
Problems with eating and sucking in case of breastfeeding (anorexia) were registered as 
feeding problems in children. The prostration of children was registered, meaning the child’s 
inability to sit upright in a child normally able to do so, or to drink in the case of children too 
young to sit.  
 
LABORATORY ANALYSIS 
The information on laboratory- and radiological investigations and current medication were 
retrieved from information in the patient’s notes. The available laboratory equipment has been 
listed in appendix 3. 
 
The hospital had one laboratory with 9 employees. The head of the laboratory, Mr.Tibaijuka 
Witness was interviewed, and some of the procedures were demonstrated. The diagnosis of 
malaria was routinely done by microscopy of a single thick blood smear collected by a finger-
prick. Fieldastain (A+B), an affordable substitution for Giemsa, was the dye used for the 
blood-smear preparation. The smears were dried in the window and subsequently investigated 
under the x100 lens of the light-microscope. For diagnosis of malaria, at least 50 fields were 
inspected, and the number of parasites was counted in proportion to 200 WBC. Three 
available light microscopes were also used for urinary analysis and faeces tests.  
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Sputum-smears coloured by Ziel-Nielsen dye were performed. Equipment for examination of 
lumbar puncture specimen fluid was also available however the procedure was not performed 
during the study-period.  HIV antibody-tests were performed routinely at the hospital. 
Specimens for CD-4 counts were sent to Mwanza. For haemoglobin-investigation the 
laboratory routinely used Corning colorimeter. Other haematological investigations such as 
full blood count (FBC), mean cell volume (MCV), mean cell haemoglobin (MCH) and cell 
morphology, could only be performed by microscopy. For biochemical-tests, the Biosystem 
Bts-305 Photometer was used. This tool could potentially be used for a vide variety of tests, 
including Polymerase Chain Reaction (PCR). However, the whole machine was currently not 
in use, due to lack of expensive reagents.  
 
Equipment for analysis of bacteriological cultures and electrolytes were not available at the 
hospital. If strictly required, electrolyte analyzes could be ordered from Bugando hospital in 
Mwanza, where a flame photometer was available       
 
ETHICAL CONSIDERATIONS  
All work was conducted under the supervision of local Doctors. Permission to conduct the 
study was obtained from the hospital-administration and the MD in charge. Patients who had 
left the room at the time of questioning or patients who were reluctant or too weak to answer 
questions were excluded from being questioned.   
 
In order to ensure patient confidentiality, the data shuts were anonymous. The names, fathers’ 
names and addresses of the patients were registered in a Master register only linked to the 
patient through the bed-number. The word “serology” was used in the questionnaire as a code 
for the observation of performed HIV-testing. 
 
STATISTICS 
Chi-square and Fisher’s exact tests (for numbers < 5) and odds ratios (ORs) with 95% 
confidence intervals (CIs) were used when studying the association between two categorical 
phenomena. To study simultaneously the impact of several variables, logistic regression 
analysis was applied on those variables where Spearman Rank coefficient was less than 0.7 
and where p<0.2 in bivariate analysis. Statistical analysis was done using the Statistical 
Package for the Social Sciences version 14 (SPSS, Chicago, IL). 
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Due to missing or illegible information from the patients’ notes, there are missing values on 
some variables. Therefore the figures do not always sum up to the number of registered 
patients.  
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 Results 
 
In the adult wards, it was manageable to include all patients seen during the major ward 
rounds. 166 patients were registered during the attended ward rounds. 50 of the patients were 
registered in the male ward, 53 were in the female ward, 37 in the children’s ward and 26 in 
the maternity ward. Due to missing values of certain variables, not all of the analyses are 
based on the same number of investigated patients. 
 
Table 1 shows that children comprised 37/102 (36%) of the registered patients. The spot-
prevalence of patients in the male ward was 25/102 (25%), 27/102 (26%) were in the female 
ward and 13/102 (13%) were in the maternity ward. 83/102 (82%) of the patients had a 
medical diagnosis, while 25/102 (25%) were registered as surgical patients. Seven out of 102 
patients presented with both surgical and medical diagnoses (7%). 
 
Patients had been hospitalised a mean of 7.2 days (range 1 - 37 days). The study showed that 
the percentage of days the patients had been hospitalised varied between the wards. 26/35 
(74%) of the children had been hospitalised ≤6 days. In the male ward 13/25 (52%), female 
ward 15/25 (60%) and in the maternity ward 8/12 (67%) had stayed ≤6 in the hospital.      
 
 
DIAGNOSIS  
As shown in table 2, malaria is by far the most frequent diagnosis in this study, followed by 
TB, HIV and a range of surgical diagnosis. 14/102 (14%) of the patients presented with TB. 7 
of the TB positive individuals (50%) had a coexisting HIV infection. In the children’s ward 
and also in the female ward we found malaria to be the most common diagnosis, whilst TB 
was most commonly found at the male ward (table 3). 
 
Other frequent diagnoses were other infections such as pneumonia and diarrhoea (appendix 1 
and 2). No lumbar punctures were conducted during the time of study despite a number of 
suspected cases of meningitis (appendix 1 and 2).  
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HIV 
Fifteen out of the 102 surveyed patients (15%) had HIV. Among the female patients, 9/58 
(16%) presented with HIV, compared to 5/40 (13%) of the male patients, in total, 55% of the 
HIV positive patients surveyed were female and 45% were male patients. As shown in figure 
5, HIV is most prevalent in the age group of 50-59, and there is also a high prevalence among 
young adults and the under five’s.  
 
Five of 97 (5%) of the patients surveyed were tested for HIV-antibodies during the 
hospitalisation for the period of study conduction. Four-in-five of the HIV tested patients 
were found to be HIV positive. One of 14 (7%) of the registered HIV-patients were infected 
with hookworm, in contrast to 1/82 (1%) of the HIV-negative patients. Schistosomiasis was 
not found in any of the groups. 
 
HIV was significantly associated with TB, 7 out of the 15 HIV positive patients had a 
coexisting TB (47%) as opposed to “only” a 9% (8/87) prevalence of TB in the HIV negative 
group. The finding remained significantly associated after entry of sex and age in the 
multivariate analysis (OR 9.8, 95% CI 3.4-28.1, p=0.001). 
 
We also found a significant association between HIV and cough, also after controlling for age 
and sex in the multivariate analysis. Ten out of 12 of the HIV patients had cough as a 
symptom (83%) as opposed to 29/57 (51%) of the HIV negative patients.   
 
TUBERCULOSIS 
The peak age groups for TB in this study were 40-49 and the age group above 60 (figure 5). 
Six out of 14 patients with TB (43%) had an x-ray finding suggesting TB. All the 13 TB 
patients in the spot-prevalence study had an existing cough during the study (100%). In 
contrast, 27 out of the 56 non-TB patients registered (48%) presented with a cough. Eight of 
14 (57%) of the TB patients were registered as recipients of tuberculostatics and Direct 
observational treatment (DOT).  
 
MALARIA 
Thirty-seven of 102 (36%) of the hospitalised patients were diagnosed with malaria. Out of 
the registered malaria patients 52% got the diagnoses without a confirmed finding of parasites 
in the blood smear. 13/ 25 (52%) were treated (for malaria) without having the diagnosis 
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verified by blood smear. The denominator varies due to missing values with regard to 
treatment.  No patient received the National Guideline first line antimalarial treatment 
(Appendix 4). 
 
Most malaria cases, 25/37 (67%), were children between 0-5 years. Out of a total of 12 
patients with more than 200 parasites per 200 WBC, 10 (83%) were children between 0-5 
years.  
 
MANAGEMENT 
We registered management in 95 cases and 90/95 (94%) of the patients received medication. 
57/95 (60%) of the patients were prescribed antibiotics, 33/95 (35%) received antimalarial 
medication. As shown in table 4, almost half of the patients with Malaria received antibiotics, 
most of them in addition to antimalarial treatment. Among the TB-group 68% received 
antibiotics in addition to tuberculostatics. 
 
At BDDH more than 50% of the patients who received antimalarial drugs received quinine. 
The second most frequent antimalarial drug in use was sulfadoxine/pyrimethamine (SP) 
tablets, either prescribed separately or in combination with quinine. The most frequently used 
antibiotics at BDDH were cloxacillin, chlorampenichol, metronidazole, gentamycine, co-
trimoxazole and phenoxymethyl penicillin.   
 
When we look at the prescribing of medication according to age, we find the peak in the 
group < 5 years. Out of the 82 patients registered for treatment, 31/82 (38%) occurred in the 
group under five years. Out of the patients receiving antimalarial drug, 23/33 (70%) were 
under the age of 5 years. The peak age group for taking antibiotics were the children under 
five years of age. 16/52 (31%) were in this group. 
 
In total 20/93 (22%) of the patients received blood-transfusion during their hospitalisation. 
53/102 (52%) of the hospitalised patients had their Hgb (haemoglobin) measured. Out of 
these 53 individuals, 5 patients (9%) had Hgb values below 4 g/dl, the hospital cut off for 
recommending blood transfusion. 3/5 of the patients in this highly anaemic group were 
diagnosed with Malaria.  
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Blood-transfusion was given to 33% of the patients diagnosed with malaria, compared to 15% 
of the patients registered with other diagnosis. This significant association between blood-
transfusion and malaria remained after entry of sex and age in the multivariate analysis (OR 
4.1, 95% CI 1.6-10.5, p=0.003).  
 
 
Figure 4:  Marianne Solberg is investigating a child suffering severe malaria. 
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 Discussion 
 
Infectious diseases accounted for the highest burden of diagnosis at BDDH. Almost 40% of 
all admitted patients in the hospital had malaria. Our data indicate that children below the age 
of five were vulnerable to develop malaria. These numbers are supported by the literature (5). 
In malaria-endemic countries in Africa such as Tanzania, between 20% and 50% of all 
hospital admissions are associated with malaria. The results from this study may be seen as 
typical for a rural Tanzanian hospital. The age distribution of malaria cases found in our study 
has also been reported previously (14).  
 
There are clear limitations in our choice of a spot prevalence study design and our small 
number of investigated patients also makes it difficult to compare our figures to existing 
literature. In most developing countries it may also be difficult to extract a full picture for 
exact health statistics in the literature (15).  
 
In the questionnaire, certain medical terms, such as dyspnoea could not easily be translated 
directly to Swahili, and were therefore translated to “kifoua kina bana” meaning discomfort at 
breathing/chest tightness. Particular symptoms, for instance “significant weight loss during 
the last three months”, were excluded from the data entry, first and foremost because a limited 
number of patients had access to scales.  
 
All patients were normally seen during the ward round, and in order to find the most reliable 
spot prevalences, also the unavailable patients were included in the study with information 
from their notes only. The patients excluded from the symptoms’ questionnaire due to 
unavailability may have represented a bias. We assume that a larger proportion of the 
healthiest patients would tend to leave their bed compared to the more severely ill patients. 
However, also the patients with decreased consciousness, who were too weak to answer, were 
excluded from the symptoms’ questionnaire. This means that the patients questioned were 
most likely around the mid point of a scale from mild to severe illness. Due to both overload 
of children in a chaotic environment and problems tracing the patient notes after the ward 
round, it was impossible to include all individuals in the children’s ward. This selection may 
have represented a bias in the study. However, the exclusion of patients from the children’s 
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ward was merely based on availability of notes. Most likely the problems with tracing 
patients’ notes were not associated with the condition of the patients and the children included 
in the study may well be representative for the hospitalised children. However this is not 
known. 
 
HIV  
Fifteen percent of the hospital population was HIV positive and had an HIV-related disease. 
This patient group must represent a considerable burden for the hospital. Women were over-
represented among HIV infected individuals, constituting a fraction of 55% of the HIV 
positive in-patients. This higher prevalence among women is consistent with existing data 
(15). World-wide, the literature points out a higher HIV prevalence among men than women. 
In sub-Saharan Africa however, more than 55% of the HIV infected individuals are women, 
compared to approximately 48% worldwide (15;16). On average, in sub-Saharan Africa there 
are approximately 13 women living with HIV for every 10 infected men (16). Figures from 
Tanzania have shown that 7.7% of the women and 6.3% of the men were HIV positive in 
2003-04 (17). In total, 7 % of Tanzanian adults were HIV positive in 2003-2004. Our figures 
are however low and results must be interpreted with caution. 
 
The age distribution of HIV patients (figure 5) is comparable to the figures found in the 2003-
04 Tanzania HIV/AIDS indicator Survey (THIS) (18) Our finding of a HIV-infection peak in 
the age-group of 50-59 is however not typical. The THIS found that prevalence for both 
women and men increase with age from the age of 15, until they reach a peak. For women the 
peak age is found to be 30-34 (13%) and for men 40-44 years old (12%) (19). In sub-Saharan 
Africa however, HIV peaks at a younger age, 25-29 is typical of many studies.  
 
Our diagnostic data will certainly not be representative of rural Tanzania, mostly because of 
the choice of a hospital population such as inclusion criteria, and because of the small number 
included in the study. The choice of a study design without a follow-up also makes it 
impossible to look at developing trends and changes in incidence and prevalence. Our study 
did neither distinguish between the two main types of the HIV virus and therefore the figures 
are not directly comparable to studies where HIV-1 is studied separately. However, HIV-1 is 
the dominant serotype in East Africa and can therefore be used as a practically accurate 
estimate for total HIV-prevalence in the region. 
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Published papers show a higher HIV prevalence in urban areas compared to rural areas 
(12;20). The THIS (21), found a prevalence in urban areas of 9.6% compared to figures in 
rural areas, with a prevalence of 4.8%. Also Kwesigabo et al. (12) found a profound 
difference between rural and urban areas in their study conducted in our Kagera Region. 
Within the urban districts of Kagera (Bukoba, map figure 2) the prevalence of HIV-1 was 
13.3% in 1996, having declined from 24.2% in 1987. In contrast, the age-adjusted prevalence 
in the most rural area studied (Karagwe, map figure 2) was “only” 2.6% in 1999. 
  
Biharamulo is a rural area, where a lower HIV rate must be anticipated. On the other hand, a 
higher prevalence is expected in a hospital population. According to the local Doctors, the 
hospital policy stated that it was mandatory for in-patients with a TB infection to do an HIV 
antibody test and thereby also to go through counselling. Also, after a staff prick-injury HIV 
tests could be demanded off patients. Pregnant women were advised but not obliged to 
undergo an HIV test. Also for diagnostic purposes HIV testing is recommended, however not 
mandatory. During the time of study, it was debated at the hospital whether HIV testing 
should be mandatory for pregnant women with suspected HIV. Only a limited number of HIV 
patients were tested for CD-4 counts in Mwanza, even though CD-4 counts according to local 
doctors were needed in the region. 
 
Since the first HIV case in 1983, figures have shown a stable prevalence or a prevalence on 
slow increase in Tanzania (15;22). According to the 2004 Joint United Nations Programme on 
HIV/ AIDS (16), there is no sign yet of an overall, national decline of HIV in any southern 
African country, except in Uganda and Zimbabwe (23). In addition, the follow-up study of 
Kwesigabo et al. (12) conducted in three districts in Kagera in the period between 1987 and 
2000 found a decline in the HIV-1 prevalence and incidence in all three districts. In the 
medium-prevalence area (Bukoba rural and Muleba districts, figure 1) the age-adjusted 
prevalence declined from 10.0% in 1987 to 4.3% in 1999. National figures from 2003 shows a 
HIV-prevalence of 8.8% in the age group 15-49 (24), as opposed to the 7 % HIV-prevalence 
among Tanzanian adults found in the THIS conducted in 2003-2004 (25). 
 
To our knowledge there are no papers on the current capacity of the Tanzanian health care to 
deliver ART (10). National guidelines on HIV-treatment in Tanzania exist, but were not 
widely implemented. At BDDH efforts are currently made to gradually introduce the ART 
supplied by the Government. 
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 TUBERCULOSIS 
There was a clear association between HIV and TB. This significant association is probably 
the main explanation for the strong association between cough and HIV found in this study. 
The diagnostic tools used for confirmation of clinical TB vary and may influence the 
statistics. In BDDH, where culture-equipment was not available, the clinical diagnosis is 
confirmed by microscopy of sputum-smears. Thereby, it is difficult to differentiate between 
Mycobacterium Tuberculosis and other species of the Mycobacterium family. However, in a 
hospital population, a higher coexistence is not surprising and may well be representative for 
other hospital populations, given that in-patients most likely have more advanced stages of 
diseases compared to ambulant patients.  
 
TB is the leading cause of death among people with HIV/AIDS and the TB infection should 
be seen in association with the HIV-epidemic (26). Since the 1980s, the rate of sputum-smear 
positive TB has risen two-fold (6). Most of this increase has been explained by the coexisting 
HIV epidemic. HIV infected patient is 500-800 times more likely to develop primary TB 
infection than other individuals, and the risk of transformation of TB from a latent state to a 
clinical state increases 30 times with coexisting HIV (26). Worldwide, statistics have shown 
that approximately 30% of the occurring TB coexists with HIV-infection (27). 
 
At BDDH at the time of the study national guidelines on management of TB were 
implemented, in contrast to HIV-guidelines, which were not yet implemented. Not all the 
patients with the TB diagnosis had records indicating reception tuberculostatics. Among the 
other TB individuals it is assumed that some received tuberculostatics even though it wasn’t 
registered in the notes while others were newly diagnosed with TB and the treatment was not 
yet commenced. A large proportion of these patients were treated with antibiotics, either in 
addition to, or without tuberculostatics. The uncertainty regarding the verification of the TB-
diagnosis and possibility of differential diagnosis such as respiratory infections may explain 
this choice of treatment. Also it must be stressed that not all the patients’ notes were properly 
documented and not all medication intended to be commenced by the doctors at the ward 
rounds was administered by the limited number of staff available. Despite the obvious 
association between HIV and TB, it is suggested that in presence of strong TB management 
programs, the impact of the HIV epidemic on TB transmission could become limited (6;6).  
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MALARIA 
Our study was conducted after the spring rainy-season. Nevertheless, malaria was by far the 
most frequent occurring diagnosis registered at BDDH. As mentioned earlier the children at 
the hospital carried the highest burden of the disease. The study has also shown that a 
relatively large number of malaria patients got the diagnosis without verification by blood-
smear.  
 
BDDH gives a good picture of a hospital in a malaria-endemic country in Africa. To give a 
better image of the malaria burden in Biharamulo it would also have been interesting to do a 
spot prevalence study in the rainy-season. According to local doctors tents were placed in the 
hospital area to be able to cope with the numerous patients with malaria in the rainy-seasons 
from November to December and February to May. 
 
In many malaria-endemic areas, there is a lack of resources and trained health personnel so 
that clinical diagnosis is the only realistic option (9). At BDDH we experienced that limited 
availability of diagnostic confirmation occurred because of lack of ability to pay for 
laboratory consumables needed for diagnostics. However, “the poor-people’s fund” at BDDH 
should cover expenses for patients not able to afford a blood-smear. One explanation for not 
taking blood-smears could be that the allowance had run out. Another explanation could be 
that the clinicians found their clinical diagnosis reliable and therefore did not find the 
procedure strictly necessary.  
 
At BDDH more than half of the patients’ prescribed antimalarial drugs received chloroquine 
and near ten patients received SP tablets. None of the malaria patients where registered with 
Artesunate, the first line treatment according to National Guidelines. The difference in price is 
obvious (28), and this could be the explanation why the staff at BDDH favoured prescribing 
the cheaper alternatives to Artesunate. 
 
In areas where malaria is highly-prevalent, clinical diagnoses may entail that all patients with 
fever – and no obvious other cause – will be treated for malaria. Attempts to improve the 
specificity of the syndromatic approach for malaria have been made. The Integrated 
Management of Childhood Illnesses (IMCI) programme have defined an algorithm in order to 
ease the problems of making the right diagnosis in rural areas such as Biharamulo with 
limited access to laboratories and special equipment . WHO suggests, with this algorithm, that 
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every febrile child living in high-risk areas for malaria should be considered to have, and be 
treated for, malaria (29). High risk areas have been defined as areas where more than 5% of 
febrile children between the ages of 2 and 59 months are parasitemic (29). 
 
The treatment policy of febrile children without a confirmatory blood-smear could lead to 
over-diagnosis and misuse of antimalarial drugs. On the other hand, prompt and effective 
treatment of malaria within 24 hours after onset of symptoms is important to prevent 
progression to severe disease and death. Babies up to two months of age are partly protected 
by maternal antibodies (30;31). As these antibodies decrease with time, they will be more 
vulnerable to severe malaria. A small child has not been subject to repeated attacks of malaria 
and has not developed a partial protective immunity (8). At BDDH we found a significant 
association between malaria and fever, a finding that supports the clinical approach performed 
by the clinicians. To evaluate the algorithms used in malaria detection, a study was done in 
Tanzania. The study showed that IMCI-trained health workers gave more correct antibiotics 
and antimalarials than colleagues who did not follow the IMCI- program, and prescribed less 
antibiotics to children not needing them (29).  
 
At BDDH almost 50% of the patients with malaria received antibiotics in addition to 
antimalarial drugs. Most frequent was the combination of chloroquine and Phenoxymethyl 
penicillin. Whether this was due to diagnostic uncertainty or the presence of a co-infection is 
unknown. In cases with severely sick children, it may be hard to distinguish the symptoms 
and different diseases. Shock-symptoms like cold, clammy skin and low blood pressure may 
be caused by many diseases. Health workers should therefore also suspect bacteraemia and 
consequently give both an antimalarial and antibiotic treatment (32). This policy and the 
knowledge of how fast bacterial disease may develop into a severe condition could explain 
the frequent use of antibiotics such as Cloxacillin and Chloramphenicol in addition to 
antimalarials (table 4).    
 
Antimalarial drug resistance has become one of the greatest challenges in malaria treatment. 
Chloroquine (CQ)-resistant Placmodium falciparum (P.falciparum) malaria has been reported 
where P.falciparum is transmitted. Chloroquine being the cheapest and by far the most widely 
available antimalarial drug, has become a large problem. A study done on Tanzanian- 
mainland from 1997-2001 concluded with a clinical-failure (median) percentage at 43% for 
CQ in treating uncomplicated P.falciparum (29).  
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 SP-resistance is now becoming more frequent in Africa as this drug is increasingly relied 
upon as a substitute for chloroquine (29). In addition, several newly developed drugs replace 
those that are no longer effective. In particular, the combination therapies with Artemether-
lumefantrine (ATM-LUM) have enormous potential in malaria therapy. The combination of 
multiple drugs makes the clinical efficacy more likely and may delay the development of 
resistance. Figures have shown a clinical failure percentage of 10.2% for SP and 3.4% for 
Amodiaquine (AQ) +SP) in treating uncomplicated malaria. These drugs are however not 
widely available and not always affordable (29). 
 
More than 30% of patients with malaria received blood transfusion during hospitalisation and 
more than half of the patients with Hgb-measurements < 4g/dl were diagnosed with malaria. 
As mentioned earlier Hgb< 4g/dl was the hospital cut-off for blood-transfusion. Malaria is 
one of the factors causing anaemia among children (33) and makes the burden of the disease 
harder to bear. We were told by local clinicians that recruiting blood donors was difficult. The 
hospital dealt with this problem, by making the patients who had received blood to give back 
to the hospital the same amount of blood as he/she had received. This was to be done before 
discharge. Together with availability the hospital had problems with storage of blood. 
On the other hand, blood-transfusion is not always the best solution in sub-Saharan Africa. 
The blood could be infected with HIV, even though it is tested for HIV-antibodies. The 
prevalence of contaminated blood varies: 0.5-20% of transfused blood in sub-Saharan Africa 
(34). The possibility of acquiring HIV-1 through blood transfusion must therefore be weighed 
against the risk of anaemia (34).    
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 Conclusion 
 
This small study in a rural Tanzanian hospital illustrates the burden of infectious diseases 
such as malaria, HIV and TB, and the considerable challenge in managing these epidemics. 
The syndromatic approach to treatment and diagnosis may be easier, faster, and hence 
cheaper. However, the diagnostic limitations due to lack of resources may impede quality of 
the provided health care. For instance at BDDH, lumbar punctures were not conducted during 
the study period and bacterial cultures were not available.  
 
Malaria was by far the most frequent diagnosis at the hospital, especially among the children. 
The difficulties in confirming malaria have been illustrated in this study. Anti-malarial 
treatment is widely in use also in-patients without confirmed parasites, and anti-malarial 
treatment is often used in combination with antibiotics to cover for the differential diagnosis. 
Where laboratory investigations are unavailable, WHO and the National Guidelines endorse 
the use of clinical diagnosis based on algorithms. However, the National Guidelines for 
treatment of malaria were not always followed, among other reasons because the first line 
treatment was more expensive. 
 
The burdens of HIV and TB have risen simultaneously in Tanzania (6), and almost half of the 
HIV patients surveyed in this study had a coexisting clinical TB infection. This strong 
association stresses the need for coping with the two epidemics in correlation. Mandatory 
HIV testing of TB individuals in accordance with the WHO guidelines are performed (35) at 
BDDH and National Guidelines on TB treatment are implemented. However TB and HIV 
patients were mixed in the hospital wards and the risk of transmission was imminent. 
Moreover, not all TB patients received anti-tuberculostatics. Furthermore, ART was still not 
administered in spite of existing national guidelines on HIV and ART. The recent plans for 
commencement of ART and the ongoing supply of drugs from the Government do however 
provide a glimmer for optimism. Nevertheless, more resources in terms of trained staff and 
laboratory equipment are essential to ensure implementation of both TB and HIV-guidelines 
and to optimise the management of malaria (29). 
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Analyses - tables 
 
 
 
 
 
Ward No of patients 
investigated 
No of beds 
in the ward 
Age group Prevalence 
Women 53 41 >5 27 
Maternity 26 32 Mothers/children 
<1 month 
13 
Children 37 44 ≥1mnth≤5 37 
Male 50 48 >5 25 
Average no of admitted patients (spot prevalence)                         102 
 
Table 1. Overview of the wards and respective number of patients and beds.     
 
Footnote: Due to chaotic conditions only 37 of the patients in the children’s ward were 
registered. With up to three children in each bed the total number of children was more than 
44, and the confusion with mixing of notes and patients made it impossible to register all 
children. 
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Main diagnosisa n (%) 
Malaria 37 (36) 
Surgical diagnosis 20 (19) 
TB 14 (14) 
Reproductive health conditions 12 (12) 
HIV/AIDSb 7 (7) 
Pneumonia 3 (2) 
Diarrhoea 2 (1) 
Cardiovascular 2 (2) 
Other infections 4 (3) 
Other diagnosis 3 (3) 
Total 102 (100) 
aThe diagnosis for which the patient was admitted. 
b8 HIV/AIDS patients were admitted with TB as the 
main diagnosis. 
 
Table 2. Distribution of hospitalised patients in different diagnostic groups. 
 
Footnote: Some diagnoses are under-represented because they have been classified under 
another main diagnose (e.g. diarrhoea classified under “malaria” and pneumocystic cariini 
pnueumonia classified in the HIV-group).    
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Diagnostic groups Children n (%) Men n (%) Women n (%) Maternity n (%) 
Malaria 27(73) 3(10) 7(26) 0(0) 
TB 2(5) 6(24) 6(23) 0(0) 
HIV 3(8) 1(4) 2(8) 1(8) 
Pneumonia 1(3) 1(2) 1(4) 0(0) 
Other infections 0(0) 2(6) 2(6) 1(4) 
Diarrhoea 1(3) 1(2) 0(0) 0(0) 
Surgical diagnosis 3(8) 10(40) 6(23) 1(4) 
Cardiovascular 0(0) 2(6) 1(2) 0(0) 
Reproductive health 
conditions 0(0) 0(0) 1(4) 11(85) 
Other diagnosis 0(0) 2(6) 2(6) 0(0) 
Spot prevalence 37/102 25/102 27/102 13/102 
 
Table 3. Diagnostic groups in the different wards. 
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  MANAGEMENT 
 
  Antimalaria Antibiotics Tuberculo-
statics 
Blood-
transfusion 
Malaria 58/68 (85%) 29/68 (43%) 0/68 (0%) 22/66 (33%)
HIV 5/29 (17%) 21/29 (72%) 9/29 (31%) 1/29 (3%) 
Tuber-
culosis 
2/28 (7%) 19/28 (68%) 16/28 (57%) 1/28 (4%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Management of malaria, HIV and TB 
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Figure 5: Distribution of malaria, HIV and TB in the different age-groups
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APPENDICES 
Main diagnosis n= %
Abruptio placenta 1 0,6
Acute abdomen 3 1,8
Anemia unknown cause 3 1,8
Apoplexia 3 1,8
Benign prostata hyperplasia 4 2,4
Burns 1 0,6
CPDa 1 0,6
Diabetes 1 0,6
Diarrhoea unknown cause 4 2,4
Endometritis 1 0,6
False labour 4 2,4
Fetal distress labour 3 1,8
Fistula 1 0,6
Fracture 5 3,0
Gastroenteritis 1 0,6
Glomerulonephritis 1 0,6
Heart failure 6 3,6
Hernia 1 0,6
HIV 4 2,4
Hypertension 1 0,6
IUFDb/Neonatal death 1 0,6
Kaposis sarcoma 1 0,6
Labour 1 0,6
Malaria 34 20,5
Marasmus 3 1,8
Meningitis 4 2,4
Neonatal/postnatal sepsis 1 0,6
Obstructed labour 4 2,4
Ophthalmological diseases 2 1,2
Opportunistic infection 1 0,6
Osteomyelitis 5 3,0
Other infections 4 2,4
PIDc 2 1,2
Placenta praevia 2 1,2
Pneumonia 12 7,2
Preeclampsia 1 0,6
Pregnancy complication 2 1,2
Psychiatric disease 2 1,2
Respiratory obstruction 1 0,6
Rheumatological diseases 3 1,8
Ruptured uterus 1 0,6
Scrotal swelling 2 1,2
Septic artritis 1 0,6
STId 1 0,6
TB  15 9,0
Trauma 9 5,4
Urogenital disorder 1 0,6
UTIe 1 0,6
Total 166 100,0
a Cephalo-pelvic dysporportion.
b Intrauterine Fetal Death 
c Pelvic Inflamatory Disease 
d Sexually Transmitted Infection 
e Urinary Tract Infection 
 
 
Appendix 1: Frequencies of main diagnosis (the diagnosis the management is based on) 
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Second diagnosis  n= % 
Abruptio placenta 1 0,6 
Anemia unknown cause 5 3 
Benign prostata hyperplasia 1 0,6 
Cellulitis 2 1,2 
Cerebral Paresis 1 0,6 
Cholera 1 0,6 
Dehydration 1 0,6 
Diabetes 1 0,6 
Diarrhoea unknown cause 4 2,4 
Fetal distress labour 3 1,8 
Fracture 1 0,6 
Gastroenteritis 1 0,6 
Heart failure 3 1,8 
HIV 18 10,8 
Hypertension 1 0,6 
Hypotension 1 0,6 
IUFD/Neonatal death 1 0,6 
Leg ulcer 1 0,6 
Malaria 13 7,8 
Malignancy 3 1,8 
Marasmus 1 0,6 
Musculo-sceletal disorders 1 0,6 
Nefrotic syndrome 2 1,2 
Neonatal/postnatalsepsis 1 0,6 
Oportunistic infection 3 1,8 
Osteomyelitis 1 0,6 
Other infections 2 1,2 
PID 1 0,6 
Pneumonia 7 4,2 
Pneumothorax 1 0,6 
Pregnancy complication 4 2,4 
Psychiatric disease 1 0,6 
Schistosomiasis 1 0,6 
Sequele after meningitis 1 0,6 
STI 1 0,6 
TB 11 6,6 
Trauma 1 0,6 
UTI 5 3 
Missing 58 35 
Total registered 108 65,1 
Total 166 100 
 
a Cephalo-pelvic dysporportion.     
b Intrauterine Fetal Death     
c Pelvic Inflamatory Disease     
d Sexually Transmitted Infection     
e Urinary Tract Infection     
 
Appendix 2: Frequencies of second diagnosis.
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 Equipment available:  
●Light microscopes (3) (Zeiss and Olympus, bulb or sunlight is amplified by a mirror)   
●Colorimeter (corning) (Used for measuring haemoglobin) 
●Haematocrit sentrifuge machine 
●Photometer (Biosystem Bts-305, used for biochemical tests)  
●Sentrifuge CN 090 
●Incubator (for culture)  
●Dip stick (Medi-Test. Test for urine analyses performed manually.) 
●Water bath 
●Scale (manual) 
●Ultrasound (Philips Sono diagnost 100LC) 
●X-ray (Philips Multi-Radiography System) 
 
 
Appendix 3: Available diagnostic equipment at Biharamulo Designated District Hospital 
 
 
 
The National guidelines for prescribing antimalarial drugs (2005):  (1) 
Uncomplicated malaria 
P.falciparum 
(uconfirmed) 
 Artemether-lumefantrine 
(ATM-LUM) 
  
P.falciparum 
(confirmed) 
 Artemether-lumefantrine 
(ATM-LUM) 
Treatment failure P.falciparum 
Quinine (Q) (for seven 
days) 
Severe malaria P.falciparum 
Quinine (Q) (for seven 
days) 
Pregnancy P.falciparum 
Sulfadoxine/Pyrimethamine 
(SP) 
 
Appendix 4: National policy and strategy for management of malaria in Tanzania. The table 
shows first line of treatment for malaria caused by P.falciparum. (Roll Back Malaria 
Monitoring and Evaluation) 
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Drug 
Tanzanian 
shilling 
American 
dollar 
Quinine tablet 35 TZS 0,03 USD 
Sulfadoxine/Pyrimethamin (SP) 
tablet 30 TZS 0,02 USD 
Artesunat tablet 1100 TZS 0,89 USD 
  
Appendix 5: The price of medication available at Biharamulo Designated District Hospital. 
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